Allogene Therapeutics (ALLO) Q1 2026 Earnings

4MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.29
-0.26
-0.22
-0.19

Details

Expected EPS
-0.225712
Actual EPS
N/A
Surprise EPS
0.23
Surprise Percent
+100%

Description

Allogene Therapeutics (ALLO) will report earnings of for Q1 2026 on March 04, 2026.

0 Comments

Share your thoughts